Chromium in the prevention and control of diabetes

Diabetes and Metabolism

Volumn 26, Issue 1, 2000, Pages 22-27

  Anderson, R A ^a,b  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

Chromium; Diabetes; Gestational diabetes; Glucose; Insulin; Steroid induced diabetes; Trace elements

Indexed keywords

CHROMIUM; GLUCOSE; INSULIN;

BLOOD GLUCOSE MONITORING; DISEASE CLASSIFICATION; DRUG MECHANISM; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PARENTERAL NUTRITION; PREGNANCY DIABETES MELLITUS; REVIEW;

ANIMALS; CHROMIUM; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INSULIN RESISTANCE; PARENTERAL NUTRITION, TOTAL; PREGNANCY;

EID: 0034099427     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. McCarty P, Zimmel P. Diabetes 1994 to 2010: global estimate and projections. Diabetes Care, 1997, 20, 1785-1790.
2. Chan JCN, Cochran CS. Diabetes in the Chinese population and its implications for health care. Diabetes Care, 1997, 20, 1785-1790.
3. Anderson RA. Chromium, glucose intolerance and diabetes. J Am Coll Nutr, 1998, 17, 548-555.
4. Schwarz K, Mertz W. A glucose tolerance factor and its differentiation from factor 3. Arch Biochem Biophys, 1957, 72, 515-518.
5. Mertz W, Schwarz K. Relationship of glucose tolerance to impaired intravenous glucose tolerance of rats on stock diets. Am J Physiol, 1959, 196, 614-618.
6. Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr, 1977, 30, 531-538.
7. Freund H, Atamian S, Fischer JE. Chromium deficiency during total parenteral nutrition. JAMA, 1979, 241, 496-498.
8. Brown RO, Forloines-Lynn S, Cross RE, Heizer WD. Chromium deficiency after long-term total parenteral nutrition. Dig Dis Sci. 1986, 31, 661-664.
9. Anderson RA. Essentiality of chromium in humans. Sci Total Environ, 1989, 86, 75-81.
10. Anderson RA, Borel JS, Polansky MM, Bryden NA, Majerus TC, Moser PB. Chromium intake and excretion of patients receiving total parenteral nutrition: effects of supplemental chromium. J Trace Elem Exptl Med, 1988, 1, 9-18.
11. Anderson RA. Chromium and parenteral nutrition. Nutrition, 1995, 11, 83-86.
12. Verhage AH, Cheong WK, Jeejeebhoy KN. Neurologic symptoms due to possible chromium deficiency in long-term parenteral nutrition that closely mimic metronidazole-induce syndromes. J Parenteral Enteral Nutr, 1996, 20, 123-127.
13. Cefalu WT, Bell-Farrou AD, Stigner J, Wang ZQ, King T, Morgan T, Terry JG. Effect of chromium picolinate on insulin sensitivity in vivo. J Trace Elem Exptl Med, 1999, 12, 71-84.
14. Anderson RA. Stress effects on chromium nutrition of humans and farm animals, in Lyons TP, Jacques KA (eds): Proc. Alltech's Tenth Symposium Biotechnology in the Feed Industry. Nottingham. England, Univ Press, 1994, 267-274.
15. Striffler JS, Law JS, Polansky MM, Bhathena SJ, Anderson RA. Chromium improves insulin response to glucose in rats. Metabolism, 1995, 44, 1314-1420.
16. Striffler JS, Polansky MM, Anderson RA. Dietary chromium decreases insulin resistance in rats fed a high fat mineral imbalanced diet. Metabolism, 1998, 47, 396-400.
17. Doisy RJ, Streeten DHP, Freiberg JM, Schneider AJ. Chromium metabolism in man and biochemical effects, in Prasad AS, Oberleas D (eds): Trace Elements in Human Health and Disease. Vol II. Essential and Toxic Elements. New York, Academic Press, 1976, 79-104.
18. Vanderlinde RE, Kayne FJ, Komar G, Simmons MJ, Tsuu JY, Lavine RL. Serum and urine levels of chromium, in Shapcott D, Hubert J (eds): Chromium in Nutrition and Metabolism. Amsterdam, Elsevier/ North Holland, 1979, 49-58.
19. Hambidge KM. Chromium nutrition in man. Am J Clin Nutr, 1974, 27, 505-514.
20. Tuman RW, Bilbo JT, Doisy RJ: Comparison and effects of natural and synthetic glucose tolerance factor in normal and genetically diabetic mice. Diabetes, 1978, 27, 49-56.
21. Anderson RA, Brantner JH, Polansky MM. An improved assay for biologically active chromium. J Agric Fd Chem, 1978, 26, 1219-1221.
22. Ravina A, Slezak L, Rubal A, Mirsky N: Clinical use of the trace element chromium (III) in the treatment of diabetes mellitus. J Trace Elem Exptl Med, 1995, 8, 183-190.
23. Nath R, Minocha J, Lyall V, et al. Assessment of chromium metabolism in maturity onset and juvenile diabetes using chromium-51 and therapeutic response of chromium administration on plasma lipids, glucose tolerance and insulin levels, in Shapcott D, Hubert J (eds): Chromium in Nutrition and Metabolism. Amsterdam, Elsevier/North Holland, 1979, 213-222.
24. Canfield W. Chromium, glucose tolerance and serum cholesterol in adults, in Shapcott D, Hubert J (eds): Chromium in Nutrition and Metabolism. Amsterdam. Elsevier/North Holland, 1979, pp. 145-161.
25. Fox GN, Sabovic Z, Chromium picolinate supplementation for diabetes mellitus. J Fam Pract, 1998, 46, 83-86.
26. Mossop RT. Effects of chromium (III) on fasting glucose, cholesterol and cholesterol HDL levels in diabetics. Cent Afr J Med, 1983, 29, 80-82.
27. Glinsmann W, Mertz W. Effect of trivalent chromium on glucose tolerance. Metabolism, 1966, 15, 510-520.
28. Evans GW: The effect of chromium picolinale on insulin controlled parameters in humans. Intl J Biosoc Med Res, 1989, 11, 163-180.
29. Roeback JR, Jr., Mae K, Chambless LE, Fletcher RH. Effects of chromium supplementation on serum high-density lipoprotien cholesterol levels in men taking beta-blockers. Ann Intern Med, 1991, 115, 917-924.
30. Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care, 1994, 17, 1449-1452.
31. Anderson RA, Cheng N, Bryden NA, Polansky MM, Chi J, Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables of people with type II diabetes. Diabetes, 1997, 46, 1786-1791.
32. Cheng N, Xixing Z, Shi H, Wu W, Chi J, Cheng J, Anderson RA. Follow-up survey of people in China with type 2 diabetes mellitus consuming supplemental chromium. J Trace Elem Exptl Med, 1999, 12, 55-60.
33. Abraham AS, Brooks BA, Eylath U. The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metabolism, 1992, 41, 768-771.
34. Sherman L, Glennon JA, Brech WJ, Klomberg GH, Gordon ES. Failure of trivalent chromium to improve hyperglycemia in diabetes mellitus. Metabolism, 1968, 17, 439-442.
35. Rabinowitz MB, Gonick HC, Levine SR, Davidson MB. Clinical trial of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Biol Trace Elem Res, 1983, 5, 449-466.
36. Uusitupa MIJ, Kumpulainen JT, Voutilainen E, et al. Effect of inorganic chromium supplementation on glucose tolerance, insulin response and serum lipids in noninsulin-dependent diabetics. Am J Clin Nutr, 1983, 338, 404-410.
37. Jovanovic-Peterson L, Peterson CM. Vitamin and mineral deficiencies which may predispose to glucose intolerance of pregnancy. J Am Coll Nutr, 1996, 15, 14-20.
38. Hambidge KM. Use of static argon atmosphere in emission spectrochemical determination of chromium in biological materials. Anal Chem, 1971, 43, 103-107.
39. Davidson IWF, Burt RL. Physiologic changes in plasma chromium of normal and pregnant women: effect of a glucose load. Am J Obstet Gynecol, 1973, 116, 601-608.
40. Mahalko JR, Bennion M. The effect of parity and time between pregnancies on maternal hair chromium concentration. Am J Clin Nutr, 1976, 29, 1069-1072.
41. Jovanovic L, Gutierrez M, Peterson CM. Chromium supplementation for women with gestational diabetes. J Trace Elem Exptl Med, 1999 12, 91-98.
42. Stojanovska L, Rosella G, Proitto J. Dexamethasone-induced increase in the rate of appearance in plasma of gut derived glucose following an oral glucose load in rats. Metabolism, 1991, 40, 297-301.
43. Venkatesan N, Davidson MB, Hutchinson A. Possible role for the glucose-fatty acid cycle in dexamethasone-induced insulin antagonism in rats. Metabolism, 1987, 36, 883.
44. Gunnarson R, Arner P, Lundgren G, Magnusson G, Ostmas J, Groth CG. Steroid diabetes after renal transplantation - a preliminary report. Scand J Urol Nephrol, 1977, 432, 191.
45. Rizza RA, Mandarino LJ, Gerich JE. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. J Clin Endocrinol Metab, 1982, 54, 131.
46. Ekstrand AV, Eriksson JG, Gronhagen-Riska C, Ahonen PJ, Groop LC. Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man. Transplanation, 1992, 53, 563-569.
47. Pagano G, Bruno A, Cavallo-Perin P, Cesco L, Imbimbo B. Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort, and betamethasone. Arch Intern Med, 1989, 149, 1098-1101.
48. Faul JL, Tormey W, Tormey V, Burke C. High dose inhaled corticosteroids and dose dependent loss of diabetic control. BMJ, 1998, 317, 1491-1492.
49. Ravina A, Slezak L, Mirsky N, Bryden NA, Anderson RA. Reversal of corticosteroid-induced diabetes with supplemental chromium. Diabetes Med, 1999, 16, 164-167.
50. Ravina A, Slezak L, Mirsky N, Anderson RA. Control of steroid-induced diabetes with supplemental chromium. J Trace Elem Exptl Med, 1999, 12, 375-378.
51. Braithwaite SS, Barr WG, Rahman A, Quddusi S. Managing diabetes during glucocorticoid therapy. How to avoid metabolic emergencies. Postgrad Med, 1998, 104, 163-166.
52. Anderson RA, Polansky MM, Bryden NA, Bhathena SJ, Canary J. Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia. Metabolism, 1987, 36, 351-355.
53. Potter JF, Levin P, Anderson RA, Freiberg JM, Andres R, Elahi D. Glucose metabolism in glucose-intolerant older people during chromium supplementation. Metabolism, 1985, 34, 199-204.
54. Davis CM, Vincent JB. Chromium oligopeptide activates insulin receptor kinase activity. Biochemistry, 1997, 36, 4382-4385.
55. Vincent JB. Mechanisms of chromium action: low-molecular-weight-chromium-binding substance. J Am Coll Nutr, 1999, 18, 6-12.
56. Imparl-Radosevich J, Deas S, Polansky MM, Baedke DA, Ingrebritsen TS, Anderson RA, Graves DJ. Regulation of phosphotyrosine tyrosine phosphatase (PTP-1) and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling. Hormone Research, 1998, 50, 177-182.
57. Davis CM, Sumall KH, Vincent JB. A biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP). Biochemistry, 1996, 35, 12963-12969.
58. Mertz W, Abernathy CO, Olin SS. Risk Assessment of Essential Elements, Washington, DC, ILSI Press, 1994: xix.
59. Anderson RA, Bryden NA, Polansky MM. Lack of toxicity of chromium chloride and chromium picolinate. J Am Coll Nutr, 1997, 16, 273-279.